Cannabinoid hyperemesis syndrome: definition, pathophysiology, clinical spectrum, insights into acute and long-term management.

Related Articles Cannabinoid hyperemesis syndrome: definition, pathophysiology, clinical spectrum, insights into acute and long-term management. J Investig Med. 2020 Oct 28;: Authors: Gajendran M, Sifuentes J, Bashashati M, McCallum R Abstract Although cannabinoid hyperemesis syndrome (CHS) was first reported more than 15 years ago, it still remains an unfamiliar clinical Read more…

Partage le savoir

Cannabinoid hyperemesis syndrome in the pregnant patient: clinical case and literature review.

Related Articles Cannabinoid hyperemesis syndrome in the pregnant patient: clinical case and literature review. Int J Emerg Med. 2020 Oct 28;13(1):52 Authors: Flament J, Scius N, Thonon H Abstract BACKGROUND: Cannabis use is on the rise. Several cases of cannabinoid hyperemesis syndrome, secondary to chronic cannabis intoxication, have been described Read more…

Partage le savoir

Thermal Degradation Kinetics and pH-Rate Profiles of Iriflophenone 3,5-C-β-d-diglucoside, Iriflophenone 3-C-β-d-Glucoside and Mangiferin in Aquilaria crassna Leaf Extract.

Related Articles Thermal Degradation Kinetics and pH-Rate Profiles of Iriflophenone 3,5-C-β-d-diglucoside, Iriflophenone 3-C-β-d-Glucoside and Mangiferin in Aquilaria crassna Leaf Extract. Molecules. 2020 Oct 23;25(21): Authors: Wongwad E, Ingkaninan K, Wisuitiprot W, Sritularak B, Waranuch N Abstract The health benefits of the Aquilaria crassna Pierre ex Lecomte leaf extract (AE) make Read more…

Partage le savoir

Using measured cannabidiol and tetrahydrocannabinol metabolites in urine to differentiate marijuana use from consumption of commercial cannabidiol products.

Related Articles Using measured cannabidiol and tetrahydrocannabinol metabolites in urine to differentiate marijuana use from consumption of commercial cannabidiol products. Clin Toxicol (Phila). 2020 Oct 29;:1-9 Authors: Goggin MM, Janis GC Abstract CONTEXT: Detecting marijuana use is a component of most urine drug screens targeting a single Δ9-tetrahydrocannabinol metabolite. Recently, Read more…

Partage le savoir

Topical Administration of Cannabidiol: Influence of Vehicle-Related Aspects on Skin Permeation Process.

Related Articles Topical Administration of Cannabidiol: Influence of Vehicle-Related Aspects on Skin Permeation Process. Pharmaceuticals (Basel). 2020 Oct 23;13(11): Authors: Casiraghi A, Musazzi UM, Centin G, Franzè S, Minghetti P Abstract Cannabidiol (CBD) is a non-psychoactive cannabinoid isolated from Cannabis sativa which, given its claimed beneficial properties and therapeutic potential, Read more…

Partage le savoir

Pancreatic Cancer (PDAC): Introduction of Evidence-Based Complementary Measures into Integrative Clinical Management.

Related Articles Pancreatic Cancer (PDAC): Introduction of Evidence-Based Complementary Measures into Integrative Clinical Management. Cancers (Basel). 2020 Oct 23;12(11): Authors: Jentzsch V, Davis JAA, Djamgoz MBA Abstract The most common form of pancreatic cancer is pancreatic ductal adenocarcinoma (PDAC), which comprises some 85% of all cases. Currently, this is the Read more…

Partage le savoir

A Critical Review of the Role of the Cannabinoid Compounds Δ9-Tetrahydrocannabinol (Δ9-THC) and Cannabidiol (CBD) and their Combination in Multiple Sclerosis Treatment.

Related Articles A Critical Review of the Role of the Cannabinoid Compounds Δ9-Tetrahydrocannabinol (Δ9-THC) and Cannabidiol (CBD) and their Combination in Multiple Sclerosis Treatment. Molecules. 2020 Oct 25;25(21): Authors: Jones É, Vlachou S Abstract Many people with MS (pwMS) use unregulated cannabis or cannabis products to treat the symptoms associated Read more…

Partage le savoir
error: Content is protected !!